Brainstorm Cell Therapeutics's activity chart (see below) currently has 11 price targets and 23 ratings on display.
Analysts' price targets on this stock were met 50% of the time, taking 513.5 days on average.
Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 23-Jul-2025. First documented stock forecast 20-Jan-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Oct-2024
$10
1 years 3 months 29 days ago
(23-Jul-2025)
0/4 (0%)
$8.07 (418.13%)
Hold Since 25-May-2022
$180
4 years 5 months 27 days ago
(25-May-2022)
7/7 (100%)
$134.85 (298.67%)
1027
What is BCLI (Brainstorm Cell Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on BCLI (Brainstorm Cell Therapeutics)?
Which analyst has the lowest performance score on BCLI (Brainstorm Cell Therapeutics) with a proven track record?
Which analyst has the most public recommendations on BCLI (Brainstorm Cell Therapeutics)?
Which analyst is the currently most bullish on BCLI (Brainstorm Cell Therapeutics)?